• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Super-Enhancer-Driven RAE1 Shows Higher Protein Levels in Tumor Compared to Adjacent Nonmalignant Stroma in High-Grade Serous Ovarian Cancer Patients.

作者信息

Berkel Caglar, Cacan Ercan

机构信息

Department of Molecular Biology and Genetics, Tokat Gaziosmanpasa University, Tokat, Turkey.

出版信息

Reprod Sci. 2023 Aug;30(8):2397-2400. doi: 10.1007/s43032-023-01199-8. Epub 2023 Feb 21.

DOI:10.1007/s43032-023-01199-8
PMID:36810690
Abstract
摘要

相似文献

1
Super-Enhancer-Driven RAE1 Shows Higher Protein Levels in Tumor Compared to Adjacent Nonmalignant Stroma in High-Grade Serous Ovarian Cancer Patients.在高级别浆液性卵巢癌患者中，超级增强子驱动的RAE1在肿瘤中的蛋白水平高于相邻的非恶性基质。
Reprod Sci. 2023 Aug;30(8):2397-2400. doi: 10.1007/s43032-023-01199-8. Epub 2023 Feb 21.
2
Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma.PH结构域富含亮氨酸重复蛋白磷酸酶、叉头框O3a型蛋白和RAD51在卵巢浆液性腺癌中的表达及其与临床病理特征和预后的关系
Chin Med J (Engl). 2017 Feb 5;130(3):280-287. doi: 10.4103/0366-6999.198932.
3
High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.伴有黏液样分化的高级别浆液性卵巢癌：1例罕见且独特病例报告，提示从高级别浆液性癌的“SET”特征向“STEM”特征转变
Diagn Pathol. 2019 Jan 12;14(1):4. doi: 10.1186/s13000-019-0781-9.
4
Cell polarity reversal in ovarian low-grade serous carcinomas and micropapillary serous borderline tumours: immunohistochemical observations.卵巢低级别浆液性癌和微乳头浆液性交界性肿瘤中的细胞极性反转：免疫组织化学观察
Histopathology. 2016 Nov;69(5):892-894. doi: 10.1111/his.13013. Epub 2016 Aug 3.
5
[Updates on histologic grading and pathogenesis of ovarian serous carcinomas].[卵巢浆液性癌的组织学分级及发病机制的最新进展]
Zhonghua Bing Li Xue Za Zhi. 2011 Aug;40(8):507-10.
6
Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging.通过环境电离质谱成像技术对浆液性卵巢癌侵袭性的代谢标志物及统计预测
Cancer Res. 2017 Jun 1;77(11):2903-2913. doi: 10.1158/0008-5472.CAN-16-3044. Epub 2017 Apr 17.
7
The prognostic values of matrix metalloproteinases in ovarian cancer.基质金属蛋白酶在卵巢癌中的预后价值。
J Int Med Res. 2020 Jan;48(1):300060519825983. doi: 10.1177/0300060519825983. Epub 2019 May 17.
8
Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.烟酰胺 N-甲基转移酶过表达可能与卵巢癌预后不良相关。
J Obstet Gynaecol. 2021 Feb;41(2):248-253. doi: 10.1080/01443615.2020.1732891. Epub 2020 Apr 14.
9
Metastatic Ovarian Serous Carcinoma of the Breast.乳腺转移性卵巢浆液性癌
Breast J. 2017 May;23(3):362-364. doi: 10.1111/tbj.12740. Epub 2016 Dec 10.
10
Outcome in serous ovarian cancer is not associated with LATS expression.浆液性卵巢癌的预后与 LATS 表达无关。
J Cancer Res Clin Oncol. 2019 Nov;145(11):2737-2749. doi: 10.1007/s00432-019-03037-4. Epub 2019 Oct 4.

引用本文的文献

1
Identification of host proteins interacting with the E protein of porcine epidemic diarrhea virus.与猪流行性腹泻病毒E蛋白相互作用的宿主蛋白的鉴定
Front Microbiol. 2024 Mar 21;15:1380578. doi: 10.3389/fmicb.2024.1380578. eCollection 2024.

本文引用的文献

1
A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer.多组学剖析卵巢癌中超增强子驱动的致癌基因表达程序。
Nat Commun. 2022 Jul 22;13(1):4247. doi: 10.1038/s41467-022-31919-8.
2
Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer.转录组分析揭示了浆液性卵巢癌中 miRNA 与肿瘤分期或分级相关的表达。
Hum Cell. 2021 May;34(3):862-877. doi: 10.1007/s13577-021-00486-3. Epub 2021 Feb 12.
3
Transcriptional control by enhancers and enhancer RNAs.
增强子和增强子RNA的转录调控。
Transcription. 2019 Aug-Oct;10(4-5):171-186. doi: 10.1080/21541264.2019.1695492. Epub 2019 Dec 2.
4
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples.近 9000 例患者样本中增强子表达的泛癌症分析。
Cell. 2018 Apr 5;173(2):386-399.e12. doi: 10.1016/j.cell.2018.03.027.
5
The role of enhancers in cancer.增强子在癌症中的作用。
Nat Rev Cancer. 2016 Aug;16(8):483-93. doi: 10.1038/nrc.2016.62. Epub 2016 Jul 1.
6
Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells.对化疗敏感和化疗耐药的卵巢癌细胞中卡铂反应的全基因组转录分析。
Mol Cancer Ther. 2005 Oct;4(10):1605-16. doi: 10.1158/1535-7163.MCT-04-0311.